Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

400-C, new FPTase inhibitor reported by Schering-Plough

Nov. 20, 1996

FPTase inhibitior series reported by Schering-Plough

Nov. 20, 1996

Fujisawa describes new agents for thrombocytopenia

Nov. 20, 1996

New farnesyl protein transferase series synthesized at Merck & Co.

Nov. 20, 1996

SKB reports D3-selective antipsychotic agents

Nov. 20, 1996

Analgesic kappa-opioid agonists reported by Pfizer

Nov. 20, 1996

Warner-Lambert claims lipid-regulating agents for vascular disease, diabetes

Nov. 20, 1996

New macrocyclic immunosuppressants from Abbott

Nov. 20, 1996

Mallinckrodt describes diagnostic agents for serotonin-related disorders

Nov. 19, 1996

Cysteine protease inhibitors revealed by Takeda

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...